Intelligent Bio Solutions is expanding its presence in the UK retail sector through the acquisition of large clients

NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS), a health technology company providing intelligent, rapid and non-invasive testing solutions, today announced the expansion of its customer network in the UK retail sector. This includes the adoption of the INBS smart fingerprint drug screening system by three of the UK’s leading retailers, some of the largest and most recognizable in the country.

The recently secured accounts employ over 55,000 people and include a UK multinational retailer specialising in clothing, footwear and accessories, a large UK retailer and kitchenware manufacturer and a UK retail group specialising in sportswear, leisurewear, footwear and equipment. Two retailers have moved from traditional third-party saliva testing to INBS fingerprint drug screening technology. The move to a more streamlined, hygienic and less invasive testing methodology has addressed operational and policy alignment issues and previous testing inefficiencies, facilitating smoother processes that enable higher testing volumes.

Doug Heathvice president of global sales at INBS, commented: “Our reach continues to expand into new sectors, demonstrating demand for drug testing beyond safety-critical industries. We see more and more companies taking proactive measures to ensure workplace safety and protect their reputation as responsible employers. We are pleased to welcome these outstanding retail partners to our growing network.”

The first-of-its-kind INBS solution uses fingerprint sweat to provide a fast, hygienic and easy-to-use drug testing method, delivering results in minutes. This unique approach tests common drugs including cocaine, cannabis, methamphetamine and opiates.

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company providing innovative, rapid, non-invasive testing solutions. The company believes its intelligent fingerprint drug screening system will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine and cannabis. By collecting samples in seconds and producing results in less than ten minutes, this technology would be a valuable tool for employers in industries where safety is critical. Additionally, the company’s biosensor platform has the potential to test for a variety of indications, from immunological disorders to infectious diseases. The company’s current customer segments include construction, manufacturing and engineering, transportation and logistics, addiction treatment organizations and coroners.

For more information visit:http://www.ibs.inc/